fingolimod hydrochloride has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Chang, B; He, X; Kang, K; Pan, D; Sun, Y | 1 |
Jin, Z; Sun, M; Weng, H; Ye, H; Yuan, Y | 1 |
Adams, DH; Frampton, J; Haldar, D; Henderson, NC; Houlihan, DD; Kalia, N; Kavanagh, D; King, A; Luu, N; Newsome, PN; Owen, A; Penny, J; Ramachandran, P; Reynolds, G; Sumption, H; Suresh, S; Than, NN | 1 |
3 other study(ies) available for fingolimod hydrochloride and Chemical and Drug Induced Liver Injury, Chronic
Article | Year |
---|---|
FTY720 attenuates APAP‑induced liver injury via the JAK2/STAT3 signaling pathway.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Fingolimod Hydrochloride; Male; Mice; Mice, Inbred C57BL; Signal Transduction | 2022 |
FTY-720 alleviates diabetes-induced liver injury by inhibiting oxidative stress and inflammation.
Topics: Animals; Chemical and Drug Induced Liver Injury, Chronic; Diabetes Mellitus, Experimental; Fingolimod Hydrochloride; Glucose; Inflammation; Liver; Mice; NF-kappa B; Oxidative Stress; Toll-Like Receptor 4 | 2023 |
Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.
Topics: Actins; Aldehyde-Lyases; Animals; Cell Line; Cell Movement; Chemical and Drug Induced Liver Injury, Chronic; Collagen Type I; Collagen Type I, alpha 1 Chain; Female; Fingolimod Hydrochloride; Gene Expression; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis; Lymph; Lysophospholipids; Macrophages; Male; Membrane Proteins; Mice; Monocytes; Neutrophils; Phosphoric Monoester Hydrolases; Phosphotransferases (Alcohol Group Acceptor); Sphingosine | 2017 |